Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US medtech industry wants proof of "broken" 510(k) process

This article was originally published in RAJ Devices

Executive Summary

The US Food and Drug Administration’s proposal to overhaul its pre-market notification, or 510(k), process for clearing most low- and moderate-risk devices may be a “premature response to popular public or media misconceptions” about the process, says medtech industry association AdvaMed1,2. The agency should first provide evidence that the need for any “fundamental changes” is warranted, it adds.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts